New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells
about
P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapyAdipose tissue dysfunction and its effects on tumor metabolismTargeting MYC Dependence by Metabolic Inhibitors in CancerRepurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agentApoptotic effects of two COX-2 inhibitors on breast adenocarcinoma cells through COX-2 independent pathway.Ibuprofen and Diclofenac Restrict Migration and Proliferation of Human Glioma Cells by Distinct Molecular Mechanisms.Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agentMetabolic Hallmarks of Tumor and Immune Cells in the Tumor MicroenvironmentRepurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agentNovel hybrids of drug with bioactive heterocycles for enhancing biological activity.Association analysis of ILVBL gene polymorphisms with aspirin-exacerbated respiratory disease in asthma.Modulation of p73 isoforms expression induces anti-proliferative and pro-apoptotic activity in mantle cell lymphoma independent of p53 status.Tumour acidosis: from the passenger to the driver's seat.Drug Repositioning for Effective Prostate Cancer Treatment.Drug Repurposing of Metabolic Agents in Malignant GliomaCombined Modulation of Tumor Metabolism by Metformin and Diclofenac in GliomaCombined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells
P2860
Q27011547-9021EF87-12FE-4FDA-892D-C1DA2E6D4EA2Q28080748-06ED828C-5347-4B95-976B-2CDE171A5729Q33608493-2FA9DE1F-30D0-434C-BE1E-7B71CB57FA11Q33893928-375FDAA2-6BE6-4DE3-8568-73A1D244A288Q35228956-5AD78D98-DC15-4068-8BE8-64B2DE5D02F9Q35814510-E22FEAE8-C06A-4851-A848-7BF262AC8DCCQ36483712-E497C2EB-4C83-48FE-AC3B-505D74AB5243Q39197674-A07CD9C8-4701-498D-8357-D16729FDC1C1Q41668110-48822C24-6E1D-47B6-8A83-E8FF8D50DD57Q46367131-D724994B-FF53-4FCD-BE26-1283BAA1E6D0Q47159407-ABE0A0EA-A50F-4A47-9D43-3AAF549995DFQ47624912-03ABD3E6-3C7D-4C4C-8737-A727004BD5F2Q47772621-C6A82FA3-E6AE-4787-A2A5-4CD08D9A7AF5Q55254671-535763F1-F3E2-47FD-B5AF-CB095D057EB6Q58738611-59D10286-B5E2-4884-B8CE-2FF19E78A24AQ58779141-C96EAA4E-9B2B-4D3F-89F7-CBD3A6B19FB0Q59132138-5B96D654-13CE-4280-9A45-115F3A3A53E1
P2860
New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells
@ast
New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells
@en
New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells
@nl
type
label
New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells
@ast
New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells
@en
New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells
@nl
prefLabel
New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells
@ast
New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells
@en
New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells
@nl
P2093
P2860
P1433
P1476
New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells
@en
P2093
Andreas Mackensen
Anton Seilbeck
Eva Gottfried
Isabel Gedig
Kathrin Renner
Katja Dettmer
Katrin Singer
Marina Kreutz
Michael Rehli
Oliver Grauer
P2860
P304
P356
10.1371/JOURNAL.PONE.0066987
P407
P577
2013-01-01T00:00:00Z